Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double Blind, Two Arm Parallel Group Study to Evaluate and Compare the Efficacy and Safety of Modified Release Tacrolimus FK506E (MR4) Versus Tacrolimus FK506 in Combination With MMF (Cellcept®) and Steroids in Patients Undergoing Kidney Transplantation
INTERVENTIONAL
Inicio: 1 de ago de 2004
ID: NCT00189839
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis
INTERVENTIONAL
Inicio: 3 de oct de 2019
ID: NCT03955445
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2b Dose-finding, Randomized, Placebo-controlled, Double-blind Study to Evaluate Efficacy and Safety of BAY 3283142 on Top of Standard of Care in Reducing Albuminuria in Patients With Chronic Kidney Disease
INTERVENTIONAL
Inicio: 8 de ago de 2024
ID: NCT06522997
Completado
ClinicalTrials.gov
Optimized vs. Standard Automated Peritoneal Dialysis Regimens (OptiStAR): A Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de jun de 2019
ID: NCT04017572
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination With Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk
INTERVENTIONAL
Inicio: 25 de jun de 2019
ID: NCT03937219
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease Including Assessment of Quality of Life
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00501046
Completado
Fase 4
ClinicalTrials.gov
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
INTERVENTIONAL
Inicio: 9 de jul de 2003
ID: NCT00168857
Activo, no recluta
Fase 2
ClinicalTrials.gov
An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN
INTERVENTIONAL
Inicio: 7 de sept de 2021
ID: NCT04572854
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
INTERVENTIONAL
Inicio: 22 de mar de 2019
ID: NCT03815643
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 17 de may de 2017
ID: NCT03021499
Completado
Fase 2
ClinicalTrials.gov
Randomised, Double-blind, Placebo-controlled and Parallel Dose Group Trial to Investigate Efficacy and Safety of Multiple Doses of Oral BI 690517 Over 14 Weeks, Alone and in Combination With Empagliflozin, in Patients With Diabetic and Non-diabetic Chronic Kidney Disease
INTERVENTIONAL
Inicio: 11 de ene de 2022
ID: NCT05182840
Aún no recluta
Fase 2
ClinicalTrials.gov
Adrenaline in Early Sepsis Resuscitation in Children- A Randomised Controlled Pilot Study in the Emergency Department (ANDES CHILD)
INTERVENTIONAL
Inicio: 1 de jul de 2024
ID: NCT06478797
Aún no recluta
Fase 2
ClinicalTrials.gov
PODOMOUNT-Basket, a Phase II, Multicentre, Randomised, 2-arm Parallel-group, Double-blind, Placebo-controlled Basket Trial to Assess Safety, Tolerability, PK, and Efficacy of BI 764198 in Four Proteinuric Kidney Diseases
INTERVENTIONAL
Inicio: 10 de mar de 2026
ID: NCT07355296
Completado
ClinicalTrials.gov
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00428220
Completado
Fase 4
ClinicalTrials.gov
Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies: a Cross-over Randomized Clinical Trail
INTERVENTIONAL
Inicio: 1 de jul de 2022
ID: NCT05402397
Completado
Fase 3
ClinicalTrials.gov
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
INTERVENTIONAL
Inicio: 22 de abr de 2008
ID: NCT00634049
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
INTERVENTIONAL
Inicio: 26 de jun de 2014
ID: NCT02174627
Completado
Fase 2
ClinicalTrials.gov
Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Semaglutide 2.4 mg, Cagrilintide 2.4 mg and Placebo in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity
INTERVENTIONAL
Inicio: 1 de abr de 2024
ID: NCT06131372
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 16 de ago de 2017
ID: NCT03242252
Completado
ClinicalTrials.gov
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
OBSERVATIONAL
Inicio: 9 de abr de 2021
ID: NCT04944433
Anterior
1
...
12
13
14
...
434
Siguiente
Filtros